Breaking News

Halo Adds COO Position

April 9, 2013

Darienzo brings 30 years of experience

Roberto Darienzo has been appointed to the newly created position of chief operating officer at Halo Pharmaceutical. Mr. Darienzo has more than 30 years of industrial experience, with 22 years in technical and international general management roles in the pharmaindustry. He has held positions at Sanofi-Aventis based in Germany, served as vice president Americas Region for Schering-Plough, and subsequently for Merck with responsibility for 13 sites in North and South America.
 
“Halo is growing very rapidly and our international expansion plans strongly support the need for this new position,” said Clive Bennett, Halo Pharmaceutical’s president and chief executive officer. “In this new role, Roberto will initially be focused on our existing Contract Pharmaceutical Development and Contract Commercial Manufacturing activities in Whippany NJ and Montreal Quebec. We are delighted to have someone of Roberto’s stature in the industry join Halo"
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments